Latest News - Zimmer Biomet
Top Corporates Hub
Zimmer Biomet
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
28.10.2025 11:30
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company's first-to-world iodine-treated total hip replacement system. This is the first product in Zimmer Biomet history to receive this designation.
Zimmer Biomet (ZBH): Evaluating Valuation After Recent Share Price Momentum
21.10.2025 01:09
Zimmer Biomet Holdings (ZBH) shares have made steady progress in recent weeks, with the stock climbing 8% over the past month. Investors seem to be weighing the company's fundamentals as it navigates a shifting healthcare landscape. See our latest analysis for Zimmer Biomet Holdings. Zimmer Biomet’s recent 8% weekly share price rally follows a period of steady long-term performance, though its 1-year total shareholder return remains slightly negative at -1.4%. This suggests that investors are...
Zimmer Biomet Q3 Earnings To Highlight Innovation And Growth - Why I Think It's A Buy
12.10.2025 04:24
Zimmer Biomet is undervalued despite recent underperformance, backed by innovation, acquisitions, and strong cash flow. Learn why ZBH stock is a buy.
Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases
08.10.2025 11:30
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, a wholly owned subsidiary, today announced the full commercial launch of two innovative solutions for complex foot and ankle trauma to offer surgeons advanced tools to address challenging pilon fractures and hindfoot injuries with precision and efficiency.
2 Safe-and-Steady Stocks on Our Buy List and 1 That Underwhelm
08.10.2025 04:35
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2025 Financial Results
03.10.2025 11:30
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Wednesday, November 5, 2025 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.
3 Reasons to Avoid ZBH and 1 Stock to Buy Instead
03.10.2025 04:01
Over the past six months, Zimmer Biomet’s stock price fell to $99.17. Shareholders have lost 12% of their capital, which is disappointing considering the S&P 500 has climbed by 24.7%. This might have investors contemplating their next move.
Robotics and MedSurg Drive Stryker Growth Amid Margin Pressures
24.09.2025 12:49
SYK posts 11% sales growth and EPS beat for Q2, driven by Mako robotics and MedSurg strength, but faces cost and margin headwinds.
Does Zimmer Biomet’s Raised Guidance and Lower Tariff Headwinds Strengthen the Bull Case for ZBH?
20.09.2025 12:49
Zimmer Biomet reported better-than-expected Q2 2025 results, with revenues of US$2.08 billion and adjusted EPS of US$2.07, leading management to raise full-year forecasted adjusted EPS to US$8.10–US$8.30 and reduce its anticipated tariff headwinds to about US$40 million. Industry analysts pointed to the company's reduced tariff impact and upwardly revised guidance as factors that set Zimmer Biomet apart among peers in a strong quarter for surgical equipment and consumables. We'll examine how...
Rothschild & Co Initiates Coverage of Zimmer Biomet Holdings (ZBH) with Buy Recommendation
19.09.2025 00:02
Do You Believe in the Upside Potential of Zimmer Biomet Holdings (ZBH)?
17.09.2025 14:27
Ariel Investments, an investment management company, released its “Ariel Global Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The second quarter marked a period of extremes. The stocks fell after the “Liberation Day” tariff announcement in early April and rebounded following the pause in tariff implementation. Enthusiasm for artificial […]
Q2 Earnings Review: Surgical Equipment & Consumables - Diversified Stocks Led by Zimmer Biomet (NYSE:ZBH)
17.09.2025 04:37
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared in Q2, starting with Zimmer Biomet (NYSE:ZBH).
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
15.09.2025 14:40
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
03.09.2025 14:50
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
1 Unpopular Stock That Deserves a Second Chance and 2 That Underwhelm
03.09.2025 05:34
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
29.08.2025 13:40
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care
28.08.2025 11:30
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointments of Jonathan M. Vigdorchik, MD, as Chief Medical Technology Advisor focused on Adult Reconstruction and Hip Implants, and Anand M. Murthi, MD, FAAOS, as Chief Medical Advisor, Shoulder, Sports, Extremities, and Trauma (S.E.T.). As strategic advisors, Drs. Vigdorchik and Murthi will leverage their extensive clinical experience to help guide the Company's new product pipeline and p
Stryker's Robotics and Global Gains Offset by Macro Concerns
22.08.2025 13:53
SYK posted strong Q2 growth driven by Mako robotics and global demand, but inflation, FX and competitive pressures temper near-term upside.
Stryker may be able to displace Zimmer in US knee reconstruction market
20.08.2025 15:27
Zimmer has maintained the largest market share since 2015, despite a higher average selling price than Stryker.